About Belhaven Biopharma
Belhaven Biopharma is a company based in Raleigh (United States) founded in 2020.. Belhaven Biopharma has raised $21 million across 4 funding rounds from investors including NCBiotech.
- Headquarter Raleigh, United States
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$21 M (USD)
in 4 rounds
-
Latest Funding Round
$10 M (USD), Series A
Aug 19, 2025
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Belhaven Biopharma
Belhaven Biopharma has successfully raised a total of $21M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $10.0M
-
First Round
First Round
(30 Jul 2021)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Series A - Belhaven Biopharma | Valuation |
investors |
|
| Jan, 2025 | Amount | Seed - Belhaven Biopharma | Valuation |
investors |
|
| Feb, 2023 | Amount | Debt – Conventional - Belhaven Biopharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Belhaven Biopharma
Belhaven Biopharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include NCBiotech. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are incubated and funded in North Carolina.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Belhaven Biopharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Belhaven Biopharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Belhaven Biopharma Comparisons
Competitors of Belhaven Biopharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Belhaven Biopharma
When was Belhaven Biopharma founded?
Belhaven Biopharma was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Belhaven Biopharma located?
Belhaven Biopharma is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Is Belhaven Biopharma a funded company?
Belhaven Biopharma is a funded company, having raised a total of $21M across 4 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $500K, raised on Jul 30, 2021.
What does Belhaven Biopharma do?
Belhaven Biopharma was founded in 2020 and is based in Raleigh, United States. Activities in the biopharmaceutical sector are conducted, with emphasis on research and development processes. Operations center on pharmaceutical advancements, though specific products or services are not publicly detailed. The companys online presence is maintained through belhavenbio.com. Limited data restricts further insights into ongoing projects or collaborations.
Who are Belhaven Biopharma's investors?
Belhaven Biopharma has 1 investor. Key investors include NCBiotech.